Vitamix Blender Cup Recall Issued Over Laceration Risks
More than 100,000 Vitamix blending containers have been recalled, following reports of customers suffering laceration injuries due to a defective design.
A Vitamix blending containers recall was announced by the U.S. Consumer Product Safety Commission (CPSC) on August 9, following at least 11 complaints involving problems where the containers separated from the blade’s base, exposing the blades and causing lacerations.
The recall includes Ascent and Venturist series 9 ounce and 20 ounce blending containers, with date codes March 2018 or earlier, which is laser-etched onto the top of the blade in the blade base. The products have a clear container with the name brand logo printed on it and a black base that was sold separately with Vitamix Model 1200 blenders.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
Blending containers marked with an orange or green dot under the base have already been repaired and are deemed safe for use.
The recalled blending containers were manufactured in the United States under Vita-Mix Corporation, of Cleveland, Ohio. They were distributed for sale at Costco and Williams-Sonoma stores nationwide and online at www.vitamix.com from April 2017 through July 2018 for between $24 and $500 for the blender and blender container.
An estimated 105,000 units were sold throughout the United States, and another 5,300 were distributed for sale to stores in Canada.
Customers are being asked to stop using the recalled blender containers immediately and to contact Vitamix at 888-847-8842 or visit them online at www.vitamix.com and navigate to the Customer Service and Voluntary Recalls link.
"*" indicates required fields
More Top Stories
A new report indicates the U.S. Navy is struggling to process tens of thousands of Camp Lejeune water poisoning claims due to a lack of resources.
A group of plaintiffs have filed a motion with the U.S. JPML seeking consolidation of all Bard implanted port lawsuits before one judge for pretrial proceedings.
A Tepezza hearing loss lawsuit accuses the manufacturer of failing to provide adequate warning about the risks of the thyroid eye disease drug.